Successful Treatment of Refractory Esophageal Crohn's Disease with Infliximab
Overview
Affiliations
Crohn's disease of esophagus, stomach and duodenum.
Pimentel A, Rocha R, Santana G World J Gastrointest Pharmacol Ther. 2019; 10(2):35-49.
PMID: 30891327 PMC: 6422852. DOI: 10.4292/wjgpt.v10.i2.35.
Crohn's Disease: Hard to Swallow!.
Nandy N, Gavin M, Martin D, McCarthy D Dig Dis Sci. 2017; 62(10):2690-2693.
PMID: 28884257 DOI: 10.1007/s10620-017-4751-3.
Oesophageal presentation of Crohn's disease.
Monteiro S, Moreira M, Ribeiro J, Cotter J BMJ Case Rep. 2017; 2017.
PMID: 28093426 PMC: 5256588. DOI: 10.1136/bcr-2016-217960.
Esophageal Crohn's disease treated "topically" with swallowed aerosolized budesonide.
Zezos P, Kouklakis G, Oikonomou A, Pitiakoudis M, Simopoulos C Case Rep Med. 2010; 2010.
PMID: 20953371 PMC: 2952909. DOI: 10.1155/2010/418769.
Perioperative adjuvant therapy with infliximab in complicated anal Crohn's disease.
Kraemer M, Kirschmeier A, Marth T Int J Colorectal Dis. 2008; 23(10):965-9.
PMID: 18553089 DOI: 10.1007/s00384-008-0500-6.